Skip to Main Content

Paper Details

Barriers and facilitators to conduct high-quality, large-scale safety and comparative effectiveness research: The Biologics and Biosimilars Collective Intelligence Consortium experience.
Pharmacoepidemiol Drug Saf
3
2020
Author NameAffiliation
Jeffrey S BrownHarvard Medical School and Harvard Pilgrim Health Care Institute
  • 1 - 1

Datasets

Release 1.2